TCV Trust & Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Buy
57,322
+19
+0% +$6.5K 1.57% 18
2026
Q1
$20.2M Sell
57,303
-128
-0.2% -$45.6K 1.69% 16
2025
Q4
$18.8M Buy
57,431
+1,048
+2% +$332K 1.52% 18
2025
Q3
$15.9M Sell
56,383
-775
-1% -$225K 1.33% 23
2025
Q2
$16M Sell
57,158
-70
-0.1% -$19.8K 1.4% 22
2025
Q1
$17.8M Sell
57,228
-42
-0.1% -$12.4K 1.65% 16
2024
Q4
$14.9M Buy
57,270
+468
+0.8% +$139K 1.38% 24
2024
Q3
$18.3M Sell
56,802
-956
-2% -$313K 1.64% 15
2024
Q2
$18M Buy
57,758
+126
+0.2% +$37K 1.72% 14
2024
Q1
$16.4M Sell
57,632
-895
-2% -$262K 1.57% 17
2023
Q4
$16.9M Sell
58,527
-845
-1% -$230K 1.7% 14
2023
Q3
$16M Buy
59,372
+376
+0.6% +$93.8K 1.76% 14
2023
Q2
$13.1M Sell
58,996
-735
-1% -$171K 1.39% 26
2023
Q1
$14.4M Buy
59,731
+396
+0.7% +$97.2K 1.6% 19
2022
Q4
$15.6M Sell
59,335
-376
-0.6% -$101K 1.77% 16
2022
Q3
$13.5M Buy
59,711
+1,086
+2% +$263K 1.71% 16
2022
Q2
$14.3M Buy
58,625
+1,067
+2% +$261K 1.71% 15
2022
Q1
$13.9M Buy
57,558
+1,124
+2% +$258K 1.48% 18
2021
Q4
$12.7M Buy
56,434
+667
+1% +$141K 1.27% 29
2021
Q3
$11.9M Buy
55,767
+127
+0.2% +$29.2K 1.31% 28
2021
Q2
$13.5M Buy
55,640
+84
+0.2% +$20.7K 1.47% 21
2021
Q1
$13.8M Sell
55,556
-392
-0.7% -$93.5K 1.6% 19
2020
Q4
$12.9M Sell
55,948
-746
-1% -$172K 1.56% 18
2020
Q3
$14.4M Sell
56,694
-604
-1% -$150K 1.94% 9
2020
Q2
$13.5M Sell
57,298
-2,329
-4% -$531K 1.92% 10
2020
Q1
$12.1M Sell
59,627
-4,738
-7% -$1.03M 1.98% 15
2019
Q4
$15.5M Buy
64,365
+282
+0.4% +$62.2K 1.88% 12
2019
Q3
$12.4M Sell
64,083
-214
-0.3% -$41.1K 1.6% 24
2019
Q2
$11.8M Buy
64,297
+633
+1% +$113K 1.54% 24
2019
Q1
$12.1M Sell
63,664
-683
-1% -$130K 1.6% 21
2018
Q4
$12.5M Sell
64,347
-223
-0.3% -$43.5K 1.83% 15
2018
Q3
$13.4M Sell
64,570
-690
-1% -$136K 1.79% 15
2018
Q2
$12M Buy
65,260
+971
+2% +$172K 1.69% 16
2018
Q1
$11M Buy
64,289
+517
+0.8% +$94.9K 1.57% 16
2017
Q4
$11.1M Buy
63,772
+212
+0.3% +$37.5K 1.55% 18
2017
Q3
$11.9M Buy
63,560
+1,263
+2% +$224K 1.75% 14
2017
Q2
$10.7M Buy
62,297
+1,744
+3% +$284K 1.62% 17
2017
Q1
$9.94M Buy
60,553
+2,247
+4% +$373K 1.52% 19
2016
Q4
$8.53M Buy
58,306
+2,436
+4% +$367K 1.38% 23
2016
Q3
$9.32M Buy
55,870
+3,687
+7% +$623K 1.58% 17
2016
Q2
$7.94M Buy
52,183
+46,843
+877% +$7.28M 1.38% 23
2016
Q1
$800K Buy
5,340
+3,120
+141% +$464K 0.14% 98
2015
Q4
$360K Hold
2,220
0.06% 131
2015
Q3
$307K Hold
2,220
0.06% 142
2015
Q2
$341K Hold
2,220
0.06% 137
2015
Q1
$355K Hold
2,220
0.06% 143
2014
Q4
$354K Sell
2,220
-450
-17% -$70.1K 0.06% 142
2014
Q3
$375K Hold
2,670
0.06% 135
2014
Q2
$316K Hold
2,670
0.05% 147
2014
Q1
$329K Buy
2,670
+67
+3% +$8.13K 0.06% 140
2013
Q4
$297K Buy
2,603
+101
+4% +$11.5K 0.05% 145
2013
Q3
$280K Sell
2,502
-62
-2% -$6.72K 0.05% 138
2013
Q2
$253K Buy
+2,564
New +$266K 0.05% 139

Other funds holding AMGN

TCV Trust & Wealth Management's AMGN Position: Q2 2026 in Review

TCV Trust & Wealth Management increased its Amgen (AMGN) stake by 0.03% in Q2 2026, buying an estimated $6.5K and bringing the position to 57,322 shares worth $20.8M. The position accounts for 1.57% of the portfolio, ranked #18.

TCV Trust & Wealth Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TCV Trust & Wealth Management held 57,322 shares of Amgen worth $20.8M as of Q2 2026.
  • TCV Trust & Wealth Management bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
  • Amgen made up 1.57% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #18 holding.
  • TCV Trust & Wealth Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.